Recessive Dystrophic Epidermolysis Bullosa Clinical Trials

32 clinical trials for Recessive Dystrophic Epidermolysis Bullosa across international registries, including 6 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• A Long-Term Safety Follow-up Registry for Patients Who Received Treatment With Prademagene Zamikeracel for Recessive Dystrophic Epidermolysis Bullosa (RDEB) in the Post-Marketing Setting — RECRUITING
• Targeting Collagen VII Antibodies With IV IgG in Dystrophic Epidermolysis Bullosa — RECRUITING · PHASE1
• GMEB-SASS: A Gene-Modified Skin Substitute for RDEB Treatment — RECRUITING · PHASE1
• A Study Comparing KB803 and Matched Placebo in Patients With Dystrophic Epidermolysis Bullosa — RECRUITING · PHASE3
• Phase I/II ex vivo gene therapy clinical trial for RDEB using autologous skin equivalent grafts genetically corrected with a COL7A1-encoding SIN retroviral vector — RECRUITING · PHASE2
• Long-Term Follow-up Protocol — RECRUITING
• Phase 4 Master Protocol for Patients Prescribed Prademagene Zamikeracel for the Treatment of Wounds — NOT_YET_RECRUITING · PHASE4
• Treatment of Dysphagia in Patients With Dystrophic Epidermolysis Bullosa With Budesonide: a Retrospective Bicentric Study Nice - Paris St Louis / Necker (EBUDE Study) — NOT_YET_RECRUITING · NA
• Targeting Collagen VII Antibodies in Bullous Diseases Using Efgartigimod IV (VYVGART) — NOT_YET_RECRUITING · PHASE1
• A Study of FCX-007 for Recessive Dystrophic Epidermolysis Bullosa — ACTIVE_NOT_RECRUITING · PHASE3
• Study of Immune Tolerance and Capacity for Wound Healing of Patients With Recessive Dystrophic Epidermolysis Bullosa (RDEB) — COMPLETED
• Pilot Study of ELK-003 Eye Drops for Treating Ocular Manifestations of Epidermolysis Bullosa — ACTIVE_NOT_RECRUITING · PHASE1
• A Pilot Study to Evaluate a Temporary Skin Substitute (Spincare® Matrix) for Wound Healing in RDEB Patients — COMPLETED · NA
• Rigosertib in Patients With Recessive Dystrophic Epidermolysis Bullosa Associated SCC — COMPLETED · PHASE1
• A Phase 3b Study for the Treatment of Dystrophic Epidermolysis Bullosa (DEB) in New and Previously EB-101 Treated Patients — ACTIVE_NOT_RECRUITING · PHASE3
• GENETICALLY-MODIFIED EPIDERMOLYSIS BULLOSA-SELF-ASSEMBLED SKIN SUBSTITUTE (GMEB-SASS) TO TREAT PATIENTS SUFFERING FROM RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA (RDEB) — NOT_YET_RECRUITING
• A Long-term Treatment With B-VEC for Dystrophic Epidermolysis Bullosa — COMPLETED · PHASE3
• Ph 3 Efficacy and Safety of B-VEC for the Treatment of DEB — COMPLETED · PHASE3
• Phase 3, Open-label Clinical Trial of EB-101 for the Treatment of Recessive Dystrophic Epidermolysis Bullosa (RDEB) — COMPLETED · PHASE3
• Extension Study to PTR-01-002 (A Study in Recessive Dystrophic Epidermolysis Bullosa (RDEB) Patients Previously Treated With PTR-01) — COMPLETED · PHASE2
• Intravenous Gentamicin Therapy for Recessive Dystrophic Epidermolysis Bullosa (RDEB) — OTHER · PHASE1
• Allogeneic ABCB5-positive Stem Cells for Treatment of Epidermolysis Bullosa — COMPLETED · PHASE1
• Clinical Trial to Assess Safety and Efficacy of Autologous Cultured Epidermal Grafts Containing Epidermal Stem Cells Genetically Modified in Patients With RDEB. — TERMINATED · PHASE1
• A Study of PTR-01 in Recessive Dystrophic Epidermolysis Bullosa — COMPLETED · PHASE2
• A Phase 1/2 Trial of PTR-01 in Adult Patients With Recessive Dystrophic Epidermolysis Bullosa (RDEB) — COMPLETED · PHASE1
• Safety and Effectiveness Study of Allogeneic Umbilical Cord Blood-derived Mesenchymal Stem Cell in Patients With RDEB — COMPLETED · PHASE1
• Molecular Signatures of Cutaneous Squamous Cell Carcinoma During Recessive Dystrophic Epidermolysis Bullosa — OTHER
• Gentamicin Therapy for Recessive Dystrophic Epidermolysis Bullosa (RDEB) Nonsense Mutation Patients — COMPLETED · PHASE1
• Safety Study of Gene-modified Autologous Fibroblasts in Recessive Dystrophic Epidermolysis Bullosa — COMPLETED · PHASE1
• Gentamicin for RDEB — COMPLETED · PHASE1
• A DOUBLE-BLIND, RANDOMIZED, CROSS-OVER, FEASIBILITY TRIAL OF PREGABALIN FOR THE TREATMENT OF RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA-ASSOCIATED NEUROPATHIC PAIN AND ITCH — COMPLETED
• Mesenchymal Stromal Cells in Adults With Recessive Dystrophic Epidermolysis Bullosa — OTHER · PHASE1

Refine this search